NEU NewMarket Corp
$887.08▲ +0.73%
Materials
Other
After hours
$887.08▲ +0.05%
Sep 11, 4:01 PM ET
Volume 96.9K
Avg Volume (10D) 121.8K
Key Metrics & Fundamentals
Market Cap
$8.16B
P/E Ratio
19.1
Div Yield
1.36%
52W Range
580.03 - 981.66
% vs 50 MA
3.60%
% vs 200 MA
20.65%
RSI-14
48.9
MACD Histogram
-9.3500
Beta (1Y vs SPY)
0.65
Free Cash Flow
$134.75M
Gross Rev
$747.09M
Gross Profit
$242.43M
EBITDA
$210.96M
COGS
$504.67M
Operating Exp
$78.76M
Operating Income
$163.67M
EBIT
$163.67M
Pretax Income
$170.34M
Net Income
$133.75M
EPS (Diluted)
14.54
Price & Volume History
Loading chart…
Recent News
NewMarket Corporation Announces Quarterly Dividend
Business Wire · Aug 13, 2026 9:01 PM
NewMarket Q2 Earnings Call Highlights
MarketBeat · Jul 31, 2026 10:03 PM
NewMarket Corp (NEU) (Q2 2026) Earnings Call Highlights: Record Net Income and Strategic ...
GuruFocus.com · Jul 31, 2026 3:00 AM
NewMarket: Q2 Earnings Snapshot
Associated Press · Jul 29, 2026 9:46 PM
NewMarket Q2 Earnings, Net Sales Rise
MT Newswires · Jul 29, 2026 9:45 PM
NewMarket Corporation Reports Second Quarter and First Half 2026 Results
Business Wire · Jul 29, 2026 9:01 PM
NewMarket Corporation Schedules Conference Call and Webcast to Review Second Quarter 2026 Results
Business Wire · Jul 13, 2026 9:01 PM
Who Is the Right Buyer for Specialty Chemicals Maker Innospec?
Trefis · Jul 8, 2026 11:38 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See NEU's money flow as a full page
Social Sentiment
Avg +0.70 · 2 posts
DiscussionNewsRiddle me this: If memory is the bottleneck to GPUs, is $NEU the bottleneck to the future of U.S. munitions?
r/wallstreetbets · Aug 9, 2026
Returns as a central theme of the post's argument.
positive
+0.60
DDNewsDiscussionTradeNeuren Pharmaceuticals (NEU): The Aspirin for the Brain 🧠💰
r/wallstreetbets · Oct 10, 2024
The post highlights NEU as a ‘big play’ in biotech and discusses its platform drug, showing strong enthusiasm.
positive
+0.80
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.